• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放疗结束与手术之间的时间间隔不会影响直肠癌的治疗效果。

The time Interval Between the End of Radiotherapy and Surgery Does Not Affect Outcomes in Rectal Cancer.

机构信息

Department of General and Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.

出版信息

Am Surg. 2023 Apr;89(4):831-836. doi: 10.1177/00031348211047215. Epub 2021 Oct 11.

DOI:10.1177/00031348211047215
PMID:34633256
Abstract

INTRODUCTION

The ideal time interval between the completion of chemoradiotherapy and subsequent surgical resection of advanced stage rectal tumors is highly debated. Our aim is to study the effect of the time interval between the completion of chemoradiotherapy and surgical resection on postoperative and oncologic outcomes in rectal cancer.

METHODS

Patients who underwent neoadjuvant chemoradiotherapy for resected locally advanced rectal tumors between 2004 and 2015 were included in this analysis. The time interval was calculated from the date of radiation completion to date of surgery. Patients were split into 2 groups based on the time interval (<8 weeks and >8 weeks). Postoperative outcomes (anastomotic leak, pathologic complete response (pCR), and readmission) and survival were assessed with multivariable logistic regression and Cox regression models while adjusting for relevant confounders.

RESULTS

200 patients (62% male) underwent resection with a median time interval of 8 weeks from completion of radiotherapy. On multivariable logistic regression, there was no significant increase in odds between time interval to surgery and anastomotic leak (aOR = .8 [.27-2.7], = .8), pCR (aOR = 1.2[.58-2.6] = .6), or readmission (aOR = 1.02, 95% CI:0.49-2.24, = .9). Time interval to surgery was not an independent prognostic factor for overall (HR = 1.04 CI = .4-2.65, = .9) and disease-free survival (HR = 1.2 CI = .5-2.9, = .6).

CONCLUSION

The time interval between neoadjuvant radiotherapy completion and surgical resection does not affect anastomotic leak rate, achievement of pCR, or overall and disease-free survival in patients with rectal cancer. Extended periods of time to surgical resection are relatively safe.

摘要

简介

放化疗完成与晚期直肠肿瘤后续手术切除之间的理想时间间隔存在高度争议。我们的目的是研究放化疗完成与手术切除之间的时间间隔对直肠癌术后和肿瘤学结果的影响。

方法

本分析纳入了 2004 年至 2015 年间接受新辅助放化疗的局部晚期直肠肿瘤患者。时间间隔从放疗完成日期计算到手术日期。根据时间间隔(<8 周和>8 周)将患者分为 2 组。术后结果(吻合口漏、病理完全缓解(pCR)和再入院)和生存情况通过多变量逻辑回归和 Cox 回归模型进行评估,同时调整了相关混杂因素。

结果

200 例(62%为男性)患者接受了切除术,放疗完成后中位时间间隔为 8 周。多变量逻辑回归分析显示,手术时间间隔与吻合口漏(比值比[aOR] =.8 [0.27-2.7], =.8)、pCR(aOR = 1.2 [0.58-2.6] =.6)或再入院(aOR = 1.02,95%CI:0.49-2.24, =.9)之间无显著相关性。手术时间间隔不是总生存(风险比[HR] = 1.04,CI =.4-2.65, =.9)和无病生存(HR = 1.2,CI =.5-2.9, =.6)的独立预后因素。

结论

新辅助放疗完成与手术切除之间的时间间隔不会影响直肠癌患者的吻合口漏发生率、pCR 获得率以及总生存和无病生存。手术切除时间延长相对安全。

相似文献

1
The time Interval Between the End of Radiotherapy and Surgery Does Not Affect Outcomes in Rectal Cancer.放疗结束与手术之间的时间间隔不会影响直肠癌的治疗效果。
Am Surg. 2023 Apr;89(4):831-836. doi: 10.1177/00031348211047215. Epub 2021 Oct 11.
2
Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.新辅助放化疗治疗直肠癌:对非紧急保肛前直肠切除术后吻合口漏率和术后膀胱功能障碍的影响。直肠癌外科质量保证多中心观察性试验的结果。
Langenbecks Arch Surg. 2010 Nov;395(8):1031-8. doi: 10.1007/s00423-010-0708-0. Epub 2010 Aug 15.
3
Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.新辅助放化疗与 TME 之间间隔时间对局部进展期直肠癌病理反应和肿瘤学结局的影响。
Ann Surg Oncol. 2012 Sep;19(9):2833-41. doi: 10.1245/s10434-012-2327-1. Epub 2012 Mar 27.
4
[Clinical features and prognosis of anastomotic leak after anterior resection for rectal cancer following neoadjuvant chemoradiotherapy].新辅助放化疗后直肠癌前切除术吻合口漏的临床特征及预后
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Jun 25;24(6):513-522. doi: 10.3760/cma.j.cn.441530-20200601-00330.
5
Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.新辅助放化疗与手术间隔时间对直肠癌患者的影响。
World J Gastroenterol. 2020 Aug 21;26(31):4624-4638. doi: 10.3748/wjg.v26.i31.4624.
6
[Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].[局部晚期高危直肠癌患者新辅助综合治疗的疗效与安全性分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):349-356. doi: 10.3760/cma.j.issn.1671-0274.2019.04.007.
7
Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.新辅助放化疗后局部晚期直肠癌达到最佳无复发生存的时间:中国大样本量中心的经验。
Int J Colorectal Dis. 2021 May;36(5):1007-1016. doi: 10.1007/s00384-020-03829-y. Epub 2021 Jan 4.
8
Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes.局部进展期直肠癌新辅助治疗与根治性手术的间隔时间:对疗效和肿瘤学结局的影响。
J Cancer Res Clin Oncol. 2014 Oct;140(10):1651-60. doi: 10.1007/s00432-014-1718-z. Epub 2014 Jun 1.
9
Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.局部晚期直肠癌新辅助放化疗后手术的最佳时机
J Am Coll Surg. 2016 Apr;222(4):367-74. doi: 10.1016/j.jamcollsurg.2015.12.017. Epub 2016 Jan 20.
10
[Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].程序性死亡蛋白1(PD-1)抗体联合全新辅助放化疗治疗具有高危因素的局部进展期中低位直肠癌的短期疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Nov 25;24(11):998-1007. doi: 10.3760/cma.j.cn441530-20210927-00386.

引用本文的文献

1
Long-term outcomes and prognostic factors of short-course radiotherapy (SCRT) in rectal cancer: a monocentric retrospective study.直肠癌短程放疗(SCRT)的长期结局及预后因素:一项单中心回顾性研究
Discov Oncol. 2024 Nov 12;15(1):645. doi: 10.1007/s12672-024-01529-5.